111 related articles for article (PubMed ID: 25091478)
41. Behcet's disease is associated with increased concentrations of antibodies against phosphatidylserine and ribosomal phosphoproteins.
Berlit P; Stueper B; Fink I; Rebmann V; Hoyer P; Kreuzfelder E; Grosse-Wilde H
Vasa; 2005 Aug; 34(3):176-80. PubMed ID: 16184836
[TBL] [Abstract][Full Text] [Related]
42. Seroreactivity against PTEN-induced putative kinase 1 (PINK1) in Turkish patients with Behçet's disease.
Vural B; Demirkan A; Ugurel E; Kalaylioglu-Wheeler Z; Esen BA; Gure AO; Gül A; Ozbek U
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S67-72. PubMed ID: 19796537
[TBL] [Abstract][Full Text] [Related]
43. Serum reactivity against herpes simplex virus type 1 UL48 protein in Behçet's disease patients and a Behçet's disease-like mouse model.
Zheng Z; Sohn S; Ahn KJ; Bang D; Cho SB
Acta Derm Venereol; 2015 Nov; 95(8):952-8. PubMed ID: 25916670
[TBL] [Abstract][Full Text] [Related]
44. [Behcet's disease and associations with HLA-B5 antigen (a review of literature and the authors' findings)].
Goloeva RG; Alekberova ZS; Guseva IA; Krylov MIu
Ter Arkh; 2010; 82(5):45-9. PubMed ID: 20597270
[TBL] [Abstract][Full Text] [Related]
45. Circulation autoantibodies against C-terminus of NuMA in patients with Behçet's disease.
Hussain M; Ma F; Chen P; Tian Y; DU H
Cent Eur J Immunol; 2020; 45(1):86-92. PubMed ID: 32425685
[TBL] [Abstract][Full Text] [Related]
46. Carbonic anhydrase I and II autoantibodies in Behçet's disease.
Mentese A; Alver A; Demir S; Sumer A; Ozer Yaman S; Karkucak M; Aydin Capkin A; Us Altay D; Turan I
Acta Reumatol Port; 2017; 42(1):26-31. PubMed ID: 28198796
[TBL] [Abstract][Full Text] [Related]
47. Autoreactivity in patients with Behçet's disease.
Taylor PV; Chamberlain MA; Scott JS
Br J Rheumatol; 1993 Oct; 32(10):908-10. PubMed ID: 7691368
[TBL] [Abstract][Full Text] [Related]
48. Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.
Clemente A; Cambra A; Munoz-Saá I; Crespí C; Pallarés L; Juan A; Matamoros N; Julià MR
Immunol Lett; 2010 Apr; 129(2):57-63. PubMed ID: 20167234
[TBL] [Abstract][Full Text] [Related]
49. Behçet's disease.
Krause I; Weinberger A
Curr Opin Rheumatol; 2008 Jan; 20(1):82-7. PubMed ID: 18281862
[TBL] [Abstract][Full Text] [Related]
50. Insights in Behçet's disease: has a target antigen been identified?
Schwartzfarb E; Kirsner RS
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):505. PubMed ID: 22327260
[No Abstract] [Full Text] [Related]
51. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
[TBL] [Abstract][Full Text] [Related]
52. Increased serum ferritin levels in active Behçet's disease.
Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
[TBL] [Abstract][Full Text] [Related]
53. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
54. Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet's disease.
Vural B; Uğurel E; Tüzün E; Kürtüncü M; Zuliani L; Cavuş F; Içöz S; Erdağ E; Gül A; Güre AO; Vincent A; Ozbek U; Eraksoy M; Akman-Demir G
J Neuroimmunol; 2011 Oct; 239(1-2):91-7. PubMed ID: 21875754
[TBL] [Abstract][Full Text] [Related]
55. Antibody response to oral streptococci in Behçet's disease.
Yokota K; Hayashi S; Fujii N; Yoshikawa K; Kotake S; Isogai E; Ohno S; Araki Y; Oguma K
Microbiol Immunol; 1992; 36(8):815-22. PubMed ID: 1474932
[TBL] [Abstract][Full Text] [Related]
56. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
57. Longitudinal study of serum antibody response to bovine corneal protein (BCP 54) in Behçet's disease.
Kong AS; Henley WL; Luntz MH
Ophthalmic Res; 1989; 21(6):401-5. PubMed ID: 2626237
[TBL] [Abstract][Full Text] [Related]
58. Antikinectin autoantibody in Behçet's disease and several other autoimmune connective tissue diseases.
Feng XG; Ye S; Lu Y; Xu XJ; Gu YY; Shen N; Ye P; Cheng FP; Wang AM; Chen SL
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S80-5. PubMed ID: 17949557
[TBL] [Abstract][Full Text] [Related]
59. Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients.
Park YK; Kim NS; Hann SK; Im S
J Dermatol Sci; 1996 Feb; 11(2):111-20. PubMed ID: 8869031
[TBL] [Abstract][Full Text] [Related]
60. Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.
Cervera R; Navarro M; López-Soto A; Cid MC; Font J; Esparza J; Reverter JC; Monteagudo J; Ingelmo M; Urbano-Márquez A
Ann Rheum Dis; 1994 Apr; 53(4):265-7. PubMed ID: 8203957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
